Kura Oncology, Inc.

12730 High Bluff Drive, San Diego, CA 92130

Kura Oncology, Inc. is a biotechnology company located at 12730 High Bluff Drive in San Diego, California, United States. The company is focused on developing precision medicines to improve the lives of cancer patients. Their innovative therapies target cancer cells specifically, aiming to increase clinical benefit and address areas of high unmet medical need. Kura Oncology is dedicated to discovering and developing novel cancer therapeutics to enhance patient outcomes and expand the number of patients who can benefit from treatment.

One of the clinical trials conducted by Kura Oncology is KOMET-007, which involves testing their menin inhibitor, ziftomenib, in combination with standard treatments for acute myeloid leukemia (AML) in patients with specific genetic mutations. The company's mission is to pioneer new approaches in cancer treatment by understanding the molecular processes driving the disease and exploring innovative combinations of therapies to improve long-term remission rates.

Patients and caregivers are at the center of Kura Oncology's work, with a focus on providing resources and support to those affected by cancer. The company's commitment to scientific innovation and collaboration is evident in their partnerships with healthcare professionals and researchers to advance the field of precision oncology.

For more information about Kura Oncology, Inc. and their research initiatives, visit their website or contact their offices in San Diego and Boston.